
The Latest in Early Detection of Pancreatic Cancer
Key Takeaways
- Pancreatic cancer's five-year survival rate has increased to 13%, driven by early-stage diagnosis and management improvements.
- Early detection remains challenging due to subtle symptoms, but advancements in precision medicine and AI offer hope.
November is Pancreatic Cancer Awareness Month and a time of year when the Pancreatic Cancer Action Network (PanCAN) reminds you about
More than 66,000 people are expected to be diagnosed this year in the United States. That’s 181 people diagnosed each day. The good news is that the five-year relative survival rate has increased to 13%, up for the third year in a row. The trend in survival rates is primarily driven by patients diagnosed with localized disease and better management of patients diagnosed at earlier stages. However, pancreatic cancer continues to be the third-leading cause of cancer-related death in men and women combined and is on track to become the second-leading cause before 2030.
Research shows
Biomarker testing of tumor tissue reveals the tumor’s biology, such as genes and proteins within the tumor. Genetic testing for
Read more about the latest in
Related to this article








